Sun Pharma Advanced Research Company Limited has reported Standalone financial results for the period ended September 30, 2023.

Sun Pharma Advanced Research Company Limited has posted net loss of Rs. 86.42 crores for the period ended September 30, 2023 as against net loss of Rs. 95.35 crores for the period ended June 30, 2023. The company posted net loss of Rs. 68.40 crores for the period ended September 30, 2022.

Sun Pharma Advanced Research Company Limited has reported total income of Rs. 29.67 crores during the period ended September 30, 2023 as compared to Rs. 34.14 crores during the period ended June 30, 2023. The company reported total income of Rs.31.60 crores during the period ended September 30, 2022.

For the Half Year ended September 30, 2023, Sun Pharma Advanced Research Company Limited has reported total income of Rs.63.81 crores as compared to Rs.60.24 crores during the 6 Months period ended September 30, 2022.

The company has posted net loss of Rs.181.77 crores for the 6 Months period ended September 30, 2023 as against net loss of Rs.150.75 crores for the 6 Months period ended September 30, 2022.